14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ACRS stock ended at $1.22. This is 8.96% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 12.29% from a day low at $1.20 to a day high of $1.35.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
May 27, 2016 $20.00 $20.00 $20.00 $20.00 65 415
May 26, 2016 $19.70 $19.70 $19.70 $19.70 18 535
May 25, 2016 $20.49 $20.49 $20.49 $20.49 48 880
May 24, 2016 $19.80 $19.80 $19.80 $19.80 33 175
May 23, 2016 $19.21 $19.21 $19.21 $19.21 79 573
May 20, 2016 $20.35 $20.35 $20.35 $20.35 33 672
May 19, 2016 $19.79 $19.79 $19.79 $19.79 36 591
May 18, 2016 $19.92 $19.92 $19.92 $19.92 39 718
May 17, 2016 $19.18 $19.18 $19.18 $19.18 78 724
May 16, 2016 $19.19 $19.19 $19.19 $19.19 84 301
May 13, 2016 $19.06 $19.06 $19.06 $19.06 149 988
May 12, 2016 $16.93 $16.93 $16.93 $16.93 13 295
May 11, 2016 $17.97 $17.97 $17.97 $17.97 19 491
May 10, 2016 $19.98 $19.98 $19.98 $19.98 34 696
May 09, 2016 $20.50 $20.50 $20.50 $20.50 27 677
May 06, 2016 $20.71 $20.71 $20.71 $20.71 26 760
May 05, 2016 $21.02 $21.02 $21.02 $21.02 29 392
May 04, 2016 $19.69 $19.69 $19.69 $19.69 31 205
May 03, 2016 $20.63 $20.63 $20.63 $20.63 40 552
May 02, 2016 $20.41 $20.41 $20.41 $20.41 27 103
Apr 29, 2016 $18.48 $18.48 $18.48 $18.48 29 167
Apr 28, 2016 $19.76 $19.76 $19.76 $19.76 48 530
Apr 27, 2016 $20.48 $20.48 $20.48 $20.48 30 632
Apr 26, 2016 $21.78 $21.78 $21.78 $21.78 39 183
Apr 25, 2016 $19.68 $19.68 $19.68 $19.68 23 005
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT